Cancer Research CR  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2347-2352, May 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michaluart, P.
Right arrow Articles by Dannenberg, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michaluart, P.
Right arrow Articles by Dannenberg, A. J.
[Cancer Research 59, 2347-2352, May 15, 1999]
© 1999 American Association for Cancer Research


Carcinogenesis

Inhibitory Effects of Caffeic Acid Phenethyl Ester on the Activity and Expression of Cyclooxygenase-2 in Human Oral Epithelial Cells and in a Rat Model of Inflammation1

Pedro Michaluart, Jaime L. Masferrer, Adelaide M. Carothers, Kotha Subbaramaiah, Ben S. Zweifel, Carol Koboldt, Juan R. Mestre, Dezider Grunberger, Peter G. Sacks, Tadashi Tanabe and Andrew J. Dannenberg2

Departments of Medicine and Surgery [K. S., A. J. D.], Joan and Sanford I. Weill Medical College of Cornell University and Anne Fisher Nutrition Center [K. S., J. R. M., A. J. D.] at Strang Cancer Prevention Center, New York, New York 10021; Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [P. M., J. R. M., P. G. S.]; Institute of Cancer Research, College of Physicians & Surgeons of Columbia University, New York, New York 10032 [A. M. C., D. G.]; Searle Discovery Research, Monsanto Co., St. Louis, Missouri 63167 [J. L. M., B. S. Z., C. K.]; and the Department of Pharmacology, National Cardiovascular Center Research Institute, Osaka 565, Japan [T. T.]

We investigated the mechanisms by which caffeic acid phenethyl ester (CAPE), a phenolic antioxidant, inhibited the stimulation of prostaglandin (PG) synthesis in cultured human oral epithelial cells and in an animal model of acute inflammation. Treatment of cells with CAPE (2.5 µg/ml) suppressed phorbol ester (12-O-tetradecanoylphorbol-13-acetate; TPA) and calcium ionophore (A23187)-mediated induction of PGE2 synthesis. This relatively low concentration of CAPE did not affect amounts of cyclooxygenase (COX) enzymes. CAPE nonselectively inhibited the activities of baculovirus-expressed hCOX-1 and hCOX-2 enzymes. TPA- and A23187-stimulated release of arachidonic acid from membrane phospholipids was also suppressed by CAPE (4–8 µg/ml). Higher concentrations of CAPE (10–20 µg/ml) suppressed the induction of COX-2 mRNA and protein mediated by TPA. Transient transfections using human COX-2 promoter deletion constructs were performed; the effects of TPA and CAPE were localized to a 124-bp region of the COX-2 promoter. In the rat carrageenan air pouch model of inflammation, CAPE (10–100 mg/kg) caused dose-dependent suppression of PG synthesis. Amounts of COX-2 in the pouch were markedly suppressed by 100 mg/kg CAPE but were unaffected by indomethacin. These data are important for understanding the anticancer and anti-inflammatory properties of CAPE.




This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
H. Yilmaz, E Uz, O Gokalp, N Ozcelik, E Cicek, and M. Ozer
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats
Toxicology and Industrial Health, September 1, 2008; 24(8): 519 - 524.
[Abstract] [PDF]


Home page
Toxicol SciHome page
O. Beltran-Ramirez, L. Aleman-Lazarini, M. Salcido-Neyoy, S. Hernandez-Garcia, S. Fattel-Fazenda, E. Arce-Popoca, J. Arellanes-Robledo, R. Garcia-Roman, P. Vazquez-Vazquez, A. Sierra-Santoyo, et al.
Evidence that the Anticarcinogenic Effect of Caffeic Acid Phenethyl Ester in the Resistant Hepatocyte Model Involves Modifications of Cytochrome P450
Toxicol. Sci., July 1, 2008; 104(1): 100 - 106.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. E. Jung, H. S. Kim, C. S. Lee, D.-H. Park, Y.-N. Kim, M.-J. Lee, J. W. Lee, J.-W. Park, M.-S. Kim, S. K. Ye, et al.
Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells
Carcinogenesis, August 1, 2007; 28(8): 1780 - 1787.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. Guney, S. Nasir, B. Oral, N. Karahan, and T. Mungan
Effect of Caffeic Acid Phenethyl Ester on the Regression of Endometrial Explants in an Experimental Rat Model
Reproductive Sciences, April 1, 2007; 14(3): 270 - 279.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
F. Oktem, H R. Yilmaz, F. Ozguner, S. Olgar, A. Ayata, E. Uzar, and E. Uz
Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester
Toxicology and Industrial Health, July 1, 2006; 22(6): 241 - 247.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
F. Ozguner, A. Altinbas, M. Ozaydin, A. Dogan, H. Vural, A N. Kisioglu, G. Cesur, and N. G. Yildirim
Mobile phone-induced myocardial oxidative stress: protection by a novel antioxidant agent caffeic acid phenethyl ester
Toxicology and Industrial Health, August 1, 2005; 21(7-8): 223 - 230.
[Abstract] [PDF]


Home page
JDRHome page
D.-B. Shieh, S.-R. Yang, X.-Y. Shi, Y.-N. Wu, and S.-N. Wu
Properties of BKCa Channels in Oral Keratinocytes
Journal of Dental Research, May 1, 2005; 84(5): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T.-W. CHUNG, S.-K. MOON, Y.-C. CHANG, J.-H. KO, Y.-C. LEE, G. CHO, S.-H. KIM, J.-G. KIM, and C.-H. KIM
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism
FASEB J, November 1, 2004; 18(14): 1670 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Marquez, R. Sancho, A. Macho, M. A. Calzado, B. L. Fiebich, and E. Munoz
Caffeic Acid Phenethyl Ester Inhibits T-Cell Activation by Targeting Both Nuclear Factor of Activated T-Cells and NF-{kappa}B Transcription Factors
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. LEVINE
Does the release of arachidonic acid from cells play a role in cancer chemoprevention?
FASEB J, May 1, 2003; 17(8): 800 - 802.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Scapagnini, R. Foresti, V. Calabrese, A. M. G. Stella, C. J. Green, and R. Motterlini
Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers
Mol. Pharmacol., March 1, 2002; 61(3): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. Fitzpatrick, J. Wang, and T. Le
Caffeic Acid Phenethyl Ester, an Inhibitor of Nuclear Factor-kappa B, Attenuates Bacterial Peptidoglycan Polysaccharide-Induced Colitis in Rats
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 915 - 920.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. Subbaramaiah, P. Bulic, Y. Lin, A. J. Dannenberg, and D. S. Pasco
Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription
J Biomol Screen, April 1, 2001; 6(2): 101 - 110.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. B. Sporn and N. Suh
Chemoprevention of cancer
Carcinogenesis, March 1, 2000; 21(3): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Weyant, A. M. Carothers, M. E. Bertagnolli, and M. M. Bertagnolli
Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways
Clin. Cancer Res., March 1, 2000; 6(3): 949 - 956.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.